BowtieNot yet claimed

About Bowtie

Bowtie is a Hong Kong-based insurer that sells health and life protection directly to consumers online, with no agents and no commissions. It was authorised in December 2018 as Hong Kong’s first virtual insurer under the Insurance Authority’s fast-track scheme, and built its name on Voluntary Health Insurance Scheme medical plans quoted, bought and claimed through a digital platform; its range has since extended across life, critical illness and other protection products, plus group medical cover and preventive healthcare services for individuals and employers. The company says it ranked first in Hong Kong’s direct channel for new individual non-single-premium policies and ninth across all channels in its July 2025 announcement.

That announcement reported annual recurring revenue above US$80 million, growth of more than 100% year over year, and more than US$16 billion of total protection provided in its first six years, and the Financial Times ranked it first among Hong Kong companies on its 2025 Asia-Pacific high-growth list. In July 2025 Bowtie secured up to US$70 million in a Series C round led by Sun Life Hong Kong — described by the company as the largest funding round for a direct-to-consumer digital health insurer in Asia — to push for a top-five position in Hong Kong medical insurance, scale preventive healthcare and expand into international markets, while continuing to operate as an associated company of Sun Life under its own brand.

Products & services

• VHIS medical insurance — Voluntary Health Insurance Scheme hospital plans sold and claimed online, with no agent commissions.
• Life and critical illness cover — term life, critical illness, cancer and accident protection products sold directly to consumers.
• Preventive healthcare — health screening and preventive services layered on top of insurance cover.
• Group medical cover — medical insurance for employers and small businesses.

Why Bowtie is listed: Its strategic backer is the Hong Kong arm of a Canadian insurance group, its stated next step is international expansion, and it is one of very few Asian virtual insurers operating at genuine scale — North American insurers and health platforms studying the direct digital model need it on the map.

How AI assistants describe Bowtie today

Questions partners ask

GlobleMatch Trust Signals

A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.

Public information coverage	8 of 9 fields on the standard profile could be filled from public sources. This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself.
Last verified	31 October 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed.

Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.

3 questions to ask this company

1. International expansion is a stated goal of the Series C — which market is first, and will it be as an insurer or through partnerships?
2. Preventive healthcare is now part of the model — is it a retention tool for policyholders, or a standalone revenue line?
3. You report more than US$100 million of protection per employee — how does the direct model’s cost structure compare with agency-led Hong Kong insurers?

Sources & verification

• Company announcement — https://www.bowtie.com.hk/blog/en/bowtie-story/bowtie-series-c-fundraising/ (up to US$70M Series C led by Sun Life Hong Kong, ARR above US$80M, protection and ranking figures as stated by the company). Checked 31 Oct 2026.
• Company website — https://www.bowtie.com.hk/ (authorised insurer status, VHIS and product range). Checked 31 Oct 2026.
• Revenue, protection and ranking figures are company-reported in the July 2025 announcement and were not independently audited by GlobleMatch.

Facts last verified: 31 October 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.

Related companies

More in Health tech: Confido Health (AI agents for healthcare administration, United States) · Vitalize (hospital workforce platform, United States)

More from Hong Kong: FundPark (e-commerce SME financing, Hong Kong) · Qupital (e-commerce trade finance, Hong Kong)

Country guides: GlobleMatch’s country guides do not cover Hong Kong yet; when a guide is published, it will list the companies from Hong Kong in this directory.